RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,000 | +22.0% | 4,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $9,840 | +172.1% | 4,000 | +150.0% | 0.00% | +200.0% |
| Q1 2023 | $3,616 | -35.2% | 1,600 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $5,584 | -90.5% | 1,600 | 0.0% | 0.00% | -88.9% |
| Q3 2022 | $59,000 | +96.7% | 1,600 | 0.0% | 0.02% | +100.0% |
| Q2 2022 | $30,000 | -30.2% | 1,600 | 0.0% | 0.01% | -18.2% |
| Q1 2022 | $43,000 | +19.4% | 1,600 | 0.0% | 0.01% | +22.2% |
| Q4 2021 | $36,000 | -14.3% | 1,600 | 0.0% | 0.01% | -25.0% |
| Q3 2021 | $42,000 | -17.6% | 1,600 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $51,000 | -8.9% | 1,600 | 0.0% | 0.01% | -6.7% |
| Q1 2021 | $56,000 | +9.8% | 1,600 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $51,000 | +8.5% | 1,600 | 0.0% | 0.02% | 0.0% |
| Q3 2020 | $47,000 | – | 1,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |